At the 65th annual American Crystallographic Association 2015 meeting in Philadelphia this week, a team from the Rockville, Md.-based National Cancer Institute presented three newly determined crystal structures that collectively provide a starting point for a drug-design effort to combat MERS.
The researchers anticipate it will take at least a year to sort through the data and begin the actual drug design. However, this method could lead to a drug that is easily administered orally, a stumbling block that has limited the appeal of other types of antiviral medications developed for the same purpose.
More articles on infection control:
46 hospitals with the fastest patient aid
Infection preventionists approve 11 C. diff prevention recommendations
US News names Best Hospitals: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
